| Primary |
| Hypertension |
23.7% |
| Metastatic Renal Cell Carcinoma |
12.9% |
| Pain |
6.1% |
| Nausea |
5.4% |
| Prophylaxis |
5.1% |
| Renal Cell Carcinoma |
5.1% |
| Diarrhoea |
4.8% |
| Hypothyroidism |
4.6% |
| Constipation |
4.1% |
| Supplementation Therapy |
3.8% |
| Diabetes Mellitus |
3.5% |
| Metastatic Malignant Melanoma |
3.1% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Hepatic Neoplasm Malignant |
2.6% |
| Depression |
2.4% |
| Insomnia |
2.1% |
| Abdominal Pain |
2.0% |
| Asthma |
2.0% |
| Back Pain |
2.0% |
| Colorectal Cancer Metastatic |
2.0% |
|
| Death |
14.1% |
| Renal Failure Acute |
6.7% |
| Cerebral Ischaemia |
5.9% |
| Hypertension |
5.9% |
| Pneumonia |
5.9% |
| Angina Pectoris |
5.2% |
| Circulatory Collapse |
5.2% |
| Renal Failure |
5.2% |
| Convulsion |
4.4% |
| Fatigue |
4.4% |
| Gastritis |
4.4% |
| Hyperbilirubinaemia |
4.4% |
| Cardio-respiratory Arrest |
3.7% |
| Chest Pain |
3.7% |
| Diverticulum Intestinal Haemorrhagic |
3.7% |
| Dyspnoea |
3.7% |
| Encephalopathy |
3.7% |
| Hepatic Encephalopathy |
3.7% |
| Cerebrovascular Insufficiency |
3.0% |
| Coma Hepatic |
3.0% |
|
| Secondary |
| Hypertension |
12.1% |
| Metastatic Renal Cell Carcinoma |
10.4% |
| Pain |
8.3% |
| Colorectal Cancer |
7.0% |
| Drug Use For Unknown Indication |
7.0% |
| Non-small Cell Lung Cancer |
6.8% |
| Colorectal Cancer Metastatic |
6.6% |
| Constipation |
6.6% |
| Product Used For Unknown Indication |
5.2% |
| Gastric Cancer |
4.4% |
| Hypothyroidism |
3.8% |
| Renal Cell Carcinoma |
3.5% |
| Diarrhoea |
3.2% |
| Nausea |
3.0% |
| Pyrexia |
2.8% |
| Abdominal Pain |
2.2% |
| Insomnia |
2.0% |
| Colon Cancer |
1.9% |
| Prophylaxis |
1.7% |
| Anxiety |
1.6% |
|
| Vomiting |
12.6% |
| Diarrhoea |
12.1% |
| Diverticulum Intestinal Haemorrhagic |
11.0% |
| Fatigue |
4.9% |
| Pneumonia |
4.9% |
| Pyrexia |
4.9% |
| Hypertension |
4.4% |
| Hypovolaemia |
4.4% |
| Nervous System Disorder |
3.8% |
| Renal Failure Acute |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Cerebrovascular Insufficiency |
3.3% |
| Dyspnoea |
3.3% |
| Gastrointestinal Disorder |
3.3% |
| Hepatic Encephalopathy |
3.3% |
| Otosalpingitis |
3.3% |
| Pulmonary Embolism |
3.3% |
| Subileus |
3.3% |
| Thrombocytopenia |
3.3% |
| Abdominal Pain |
2.7% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
32.5% |
| Renal Cell Carcinoma |
14.5% |
| Depression |
11.1% |
| Pain |
6.8% |
| Insomnia |
3.4% |
| Neuroendocrine Carcinoma Metastatic |
3.4% |
| Anxiety |
2.6% |
| Metastases To Bone |
2.6% |
| Nausea |
2.6% |
| Neoplasm |
2.6% |
| Vomiting |
2.6% |
| Abdominal Pain Upper |
1.7% |
| Cardiac Failure Chronic |
1.7% |
| Fatigue |
1.7% |
| Flatulence |
1.7% |
| Hyperuricaemia |
1.7% |
| Metastatic Pain |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Renal Cancer Metastatic |
1.7% |
| Ventricular Extrasystoles |
1.7% |
|
| Delirium |
30.8% |
| Vomiting |
10.3% |
| Anorectal Infection |
5.1% |
| Fatigue |
5.1% |
| Gamma-glutamyltransferase Increased |
5.1% |
| Somnolence |
5.1% |
| Weight Decreased |
5.1% |
| C-reactive Protein Increased |
2.6% |
| Eosinophil Count Increased |
2.6% |
| Hypertensive Crisis |
2.6% |
| Lymphopenia |
2.6% |
| Malignant Neoplasm Progression |
2.6% |
| Neutropenia |
2.6% |
| Off Label Use |
2.6% |
| Osteonecrosis Of Jaw |
2.6% |
| Pneumonitis |
2.6% |
| Psychomotor Skills Impaired |
2.6% |
| Rash |
2.6% |
| Staphylococcal Infection |
2.6% |
| Swelling |
2.6% |
|
| Interacting |
| Pancreatic Carcinoma |
57.1% |
| Atrial Fibrillation |
42.9% |
|
| Rectal Haemorrhage |
50.0% |
| Small Intestinal Obstruction |
50.0% |
|
